Kawamoto Ryuichi, Kikuchi Asuka, Ninomiya Daisuke, Kumagi Teru
Department of Community Medicine, Ehime University Graduate School of Medicine, Toon, JPN.
Cureus. 2024 Jan 13;16(1):e52224. doi: 10.7759/cureus.52224. eCollection 2024 Jan.
Introduction An elevated ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) not only independently affects aging-related health but also plays a critical role in mortality. However, there is limited predictive data on all-cause mortality, particularly in the context of community-dwelling individuals in Japan. This study examined the association between the AST/ALT ratio and survival prognosis in a cohort study using two follow-up studies based on 19-year and 7-year intervals. Methods The study included 1,573 male (63 ± 14 years; range, 20-90 years) and 1,980 female participants (65 ± 12 years; range, 19-89 years). The participants were those involved in a Nomura cohort study conducted in 2002 (first cohort) and 2014 (second cohort) that continued to participate throughout the follow-up periods (follow-up rates were 90.3% and 97.4% for each cohort). A Cox proportional hazards model was adopted to calculate the multivariate-adjusted hazard ratios (HRs) of death from the baseline health check-up to the follow-up periods while controlling for potential confounding factors. Results The follow-up survey revealed that there were 473 male deaths (30.1% of total male participants) and 432 female deaths (21.8% of total female participants). The univariate Cox regression analysis showed that HRs for all-cause mortality were greater for participants in higher AST/ALT ratio quartiles ( < 0.001). The multivariate Cox regression analysis with adjusted variables showed a significant association between those in the fourth AST/ALT ratio quartile (HR: 1.83, 95% confidence interval, 1.46-2.29) and the risk of all-cause mortality. This association holds irrespective of gender, age, and elevated gamma-glutamyl transpeptidase, particularly in the case of participants with a body mass index < 25 kg/m without a history of cardiovascular disease or diabetes. Conclusions Our results reveal that an elevated AST/ALT ratio is an independent factor that can predict the risk of all-cause mortality among community-dwelling individuals.
引言 天冬氨酸氨基转移酶(AST)与丙氨酸氨基转移酶(ALT)的比值升高不仅独立影响与衰老相关的健康状况,而且在死亡率方面起着关键作用。然而,关于全因死亡率的预测数据有限,尤其是在日本社区居住人群中。本研究在一项队列研究中,通过两项间隔19年和7年的随访研究,检验了AST/ALT比值与生存预后之间的关联。
方法 本研究纳入了1573名男性参与者(63±14岁;范围20 - 90岁)和1980名女性参与者(65±12岁;范围19 - 89岁)。这些参与者来自2002年(第一队列)和2014年(第二队列)进行的野村队列研究,并在整个随访期间持续参与(每个队列的随访率分别为90.3%和97.4%)。采用Cox比例风险模型计算从基线健康检查到随访期间死亡的多变量调整风险比(HR),同时控制潜在的混杂因素。
结果 随访调查显示,男性死亡473例(占男性参与者总数的30.1%),女性死亡432例(占女性参与者总数的21.8%)。单变量Cox回归分析表明,AST/ALT比值较高四分位数的参与者全因死亡率的HR更高(<0.001)。调整变量后的多变量Cox回归分析显示,AST/ALT比值第四四分位数的参与者与全因死亡风险之间存在显著关联(HR:1.83,95%置信区间,1.46 - 2.29)。这种关联不受性别、年龄和γ-谷氨酰转肽酶升高的影响,特别是对于体重指数<25kg/m²且无心血管疾病或糖尿病病史的参与者。
结论 我们的结果表明,AST/ALT比值升高是预测社区居住人群全因死亡风险的一个独立因素。